Skip to content

Effects of Bariatric Surgery on Inspiratory Metaboreflex in Obese Subjects

Effects of Bariatric Surgery on Inspiratory Metaboreflex in Metabolically Healthy Obese and Obese Subjects With Metabolic Syndrome

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03056937
Enrollment
45
Registered
2017-02-17
Start date
2016-02-01
Completion date
2018-12-01
Last updated
2017-02-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Metabolic Syndrome, Obesity

Brief summary

The hypothesis of this study is that reductions in body weight could improve inspiratory muscle function attenuating the inspiratory metaboreflex in metabolically healthy obese individuals and obese individuals with metabolic syndrome.

Detailed description

Introduction: Peripheral metaboreflex activation appears to be exacerbated in obese individuals with metabolic syndrome. Interestingly, bariatric surgery attenuates the peripheral metaboreflex. Obese individuals have impaired inspiratory muscle function, which can be reversed by the reduction in body weight. Therefore, bariatric surgery could attenuate inspiratory metaboreflex in metabolically healthy obese individuals and obese individuals with metabolic syndrome. Objectives: To investigate the effects of bariatric surgery on inspiratory metaboreflex in metabolically healthy obese individuals and in obese patients with metabolic syndrome. Patients and Methods: A sample comprising of 15 obese subjects with metabolic syndrome, 15 obese subjects without metabolic syndrome and 15 healthy nonobese individuals. These subjects will be submitted to pulmonary function, respiratory muscle strength, inspiratory muscle resistance, exercise tolerance, quality of life, autonomic cardiovascular control and the inspiratory metaboreflex evaluation. The evaluations performed in obese patients with and without metabolic syndrome pre-surgery will be repeated 6 months after bariatric surgery.

Interventions

OTHERBariatric surgery

evaluations pre and post bariatric surgery.

OTHERControl

without intervention, it will be performed only evaluations

Sponsors

University of Cruz Alta
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

Obese with Metabolic Syndrome Inclusion Criteria: * Body mass index (BMI)\> 35 kg / m² * Diagnosis of metabolic syndrome

Exclusion criteria

* Acute health problems in the last month (viral or bacterial infections, accidents, allergic reactions) * Diseases of the nervous system or conditions that affect the understanding or participation in the study * Pregnancy * Type I diabetes mellitus * Arterial hypertension * Dyslipidemias * Coronary artery disease * Left ventricular dysfunction * Any condition interfering with locomotion * Bronchial asthma * Chronic obstructive pulmonary disease * Chronic neuropathies * Use of drugs such as corticosteroids or bronchodilators * Smokers. Obese without Metabolic Syndrome Inclusion Criteria: * Body mass index (BMI)\> 35 kg / m²

Design outcomes

Primary

MeasureTime frameDescription
Inspiratory metaboreflex6 monhsIt will be induced through a linear inspiratory resistance of 60% of maximal inspiratory pressure

Secondary

MeasureTime frameDescription
Respiratory muscle strength6 monthsIt will be determined by manovacuometry.
Inspiratory muscle resistance6 monthsIt will be evaluated through a protocol with progressive increase in inspiratory resistance.
Pulmonary function6 monthsIt will be assessed by spirometry
Exercise tolerance6 monthsIt will be determined by the 6-minute walk test.
Quality of life6 monthsIt will be determined through the SF36 questionnaire.
Autonomic cardiovascular control6 monthsIt will be determined by spectral analysis

Countries

Brazil

Contacts

Primary ContactCarine C Callegaro, PhD
ccallegaro@unicruz.edu.br+55 (55) 99914-6712

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026